Public Advisory - TUMS Peppermint Regular Strength tablets: One lot recalled due to contamination
OTTAWA, ON, Nov. 30, 2022 /CNW/ - Summary
Product: TUMS Peppermint Regular Strength tablets, packages of three rolls of 12 tablets, lot HA7H, NPN 01970240
Issue: Health product ? contamination, product safety
What to do: Stop using the recalled product. Speak to a health care professional if you have taken this product and have health concerns.
Affected products
Product
NPN
Lot
Expiry
TUMS Peppermint Regular Strength (500mg) tablets, packages of three rolls of 12 tablets
01970240
HA7H
August 2027
Issue
GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil. The product is sold in a package of three rolls containing 12 tablets each, and was distributed across Canada starting on October 25, 2022.
TUMS is an antacid indicated for adult use to relieve indigestion and heartburn caused by too much acid in the stomach.
If consumed, the fragments should pass through most people's digestive systems with no concern; however, elderly people and people who have narrow areas in their intestines because of disease or surgery may be at risk of injury.
Health Canada is monitoring the company's recall and will update the public if any new health risks are identified.
What you should do
Stop using the recalled product. Contact your health care practitioner if you have used this product and have concerns about your health.
Follow municipal or regional guidelines on how to dispose of chemicals and other hazardous waste; or
Return the product to your local pharmacy for proper disposal
Contact GSK Consumer Healthcare (doing business as Haleon) by calling 1-905-507-7000, or by emailing [email protected], if you have questions about this recall.
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to...
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....